Key Takeaways From Privia Health Gr Analyst Ratings
Portfolio Pulse from Benzinga Insights
Analysts have mixed views on Privia Health Group (NASDAQ: PRVA) with recent ratings showing a shift towards somewhat bullish sentiments. The average 12-month price target has decreased by 7.52% to $22.5. Key analysts have maintained or lowered their ratings and price targets, reflecting dynamic market conditions and company performance.
August 14, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Analysts have mixed views on Privia Health Group with a shift towards somewhat bullish sentiments. The average 12-month price target has decreased by 7.52% to $22.5, indicating a cautious outlook.
The mixed analyst ratings and the decrease in the average price target suggest a cautious outlook for PRVA. While some analysts maintain an 'Outperform' rating, others have lowered their price targets, reflecting concerns over the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100